Remote Simultaneous Medical Interpreting and Medical Outcomes (RSMI)

This study has been completed.
Sponsor:
Collaborators:
The California Endowment
The Commonwealth Fund
Information provided by:
New York University School of Medicine
ClinicalTrials.gov Identifier:
NCT00522327
First received: August 27, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted
  Purpose

All new patients to the general medicine clinic who were not primarily English speaking were randomized, after consenting, to receieve either remote simultaneous medical interpreting or usual and customary interpreting services. Patient charts were followed for one year after enrollment to assess medical outcomes, including patient satisfaction, diabetes management, lipid management, depression screening and management, vaccine administration.

All Spanish-speaking ER patients were similarly enrolled. They were followed for one ER visit and their knowledge of exit instructions was assessed, as well as their satisfaction with care.


Condition Intervention
Diabetes
Other: remote simultaneous medical interpreting
Other: usual and customary
Other: ENglish speaking

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Official Title: Remote Simultaneous Medical Interpretation: Medical Outcomes

Resource links provided by NLM:


Further study details as provided by New York University School of Medicine:

Primary Outcome Measures:
  • Adherence with care [ Time Frame: one year ]

Secondary Outcome Measures:
  • care parameters [ Time Frame: one year ]

Enrollment: 1200
Study Start Date: November 2004
Study Completion Date: October 2006
Arms Assigned Interventions
Experimental: 1
remote simult med interpret
Other: remote simultaneous medical interpreting
remote simultaneous medical interpretation
Active Comparator: 2
Usual & Customary
Other: usual and customary
usual and customary interpreting
3
comparison group
Other: ENglish speaking
English speakers

  Eligibility

Ages Eligible for Study:   18 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Limited English-speaking
  • English-speaking
  • New patient in medicine clinic
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00522327

Sponsors and Collaborators
New York University School of Medicine
The California Endowment
The Commonwealth Fund
Investigators
Principal Investigator: Francesca M Gany, MD., M.S. New York University School of Medicine
  More Information

No publications provided by New York University School of Medicine

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00522327     History of Changes
Other Study ID Numbers: Calendow/CMWF
Study First Received: August 27, 2007
Last Updated: August 27, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by New York University School of Medicine:
Immigrant
Interpreting

ClinicalTrials.gov processed this record on July 26, 2014